This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Fincher C, Nordstrom B, Fraeman KH, Collins JM, Bennett R, Al-Sabbagh A, Meletiche D.Treatment of multiple sclerosis with natalizumab and interferon-beta-1a subcutaneous: a healthcare utilization study. World Congress on Treatment and Research in Multiple Sclerosis: abstr. P467, 17 Sep 2008. Available from: URL: http://www.msmontreal.org
Rights and permissions
About this article
Cite this article
Natalizumab in MS costly. Pharmacoecon. Outcomes News 563, 7 (2008). https://doi.org/10.2165/00151234-200805630-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805630-00015